Thomas P. Condon - Concepedia

Author

Thomas P. Condon

Also Known As

T Condon, T P Condon, T. Condon, T. P. Condon, T.P Condon, T.P. Condon, THOMAS P. CONDON, Thomas B. Condon, Thomas Condon, Thomas P. Condon

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

Ionis Pharmaceuticals (United States)Texas Medical Center The University of Texas Health Science Center at Houston University of California San Diego The University of Texas at Austin

About

Thomas P. Condon is an author at Ionis Pharmaceuticals (United States) specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.2K
2	Natural Sciences	3	3	373
3	Allergy	1	1	201
4	Biochemistry	1	1	18
5	Biomedical Engineering	1	1	54

Thomas P. Condon

Publications

2.1K

Citations

H-Index

Page 1

	Year	Citations
2′-O-(2-Methoxy)ethyl-modified Anti-intercellular Adhesion Molecule 1 (ICAM-1) Oligonucleotides Selectively Increase the ICAM-1 mRNA Level and Inhibit Formation of the ICAM-1 Translation Initiation Complex in Human Umbilical Vein Endothelial Cells Brenda F. Baker, Sidney S. Lot, Thomas P. Condon, Journal of Biological Chemistry	1997	374
Inhibition of protein kinase C-alpha expression in human A549 cells by antisense oligonucleotides inhibits induction of intercellular adhesion molecule 1 (ICAM-1) mRNA by phorbol esters. Nicholas M. Dean, Robert A. McKay, Thomas P. Condon, Journal of Biological Chemistry Cell AdhesionImmunologyMolecular BiologyHuman A549 CellsInflammation	1994	292
Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides. C. Frank Bennett, Thomas P. Condon, S Grimm, The Journal of Immunology InflammationCell Surface ExpressionAngiogenesisCell AdhesionImmunology	1994	253
Role of the intercellular adhesion molecule-1(ICAM-1) in endotoxin-induced pneumonia evaluated using ICAM-1 antisense oligonucleotides, anti-ICAM-1 monoclonal antibodies, and ICAM-1 mutant mice. Takashi Kumasaka, W M Quinlan, N A Doyle, Journal of Clinical Investigation InflammationIcam-1 MrnaInflammatory Lung DiseaseAllergyLung Inflammation	1996	201
Cleavage of L1 in Exosomes and Apoptotic Membrane Vesicles Released from Ovarian Carcinoma Cells Paul Gutwein, Alexander Stoeck, Svenja Riedle, Clinical Cancer Research	2005	198
Blocking of heart allograft rejection by intercellular adhesion molecule-1 antisense oligonucleotides alone or in combination with other immunosuppressive modalities. S M Stepkowski, Yan Tu, Thomas P. Condon, The Journal of Immunology Cell AdhesionImmunologyImmunotherapyIntercellular Adhesion Molecule-1Inflammation	1994	143
The role of ADAM10 and ADAM17 in the ectodomain shedding of angiotensin converting enzyme and the amyloid precursor protein Tobias M. J. Allinson, Edward T. Parkin, Thomas P. Condon, European Journal of Biochemistry	2004	91
IL-1 and TNF independent pathways mediate ICAM-1/VCAM-1 up-regulation in ischemia reperfusion injury Melissa J. Burne, Mahmud Haq, Sabiha R. Saba, Journal of Leukocyte Biology ImmunologyRenal InflammationPathologyIcam-1/vcam-1 Up-regulationImmunotherapy	2001	75
ADAM17 but Not ADAM10 Mediates Tumor Necrosis Factor-α and L-Selectin Shedding from Leukocyte Membranes Thomas P. Condon, Shin Flournoy, Glenn J. Sawyer, Antisense and Nucleic Acid Drug Development Immune RegulationImmunologyPathologyImmune SystemImmune Dysregulation	2001	63
PROTECTION AGAINST ALLOGRAFT REJECTION WITH INTERCELLULAR ADHESION MOLECULE-1 ANTISENSE OLIGODEOXYNUCLEOTIDES1 Stanislaw M. Stepkowski, Mouer Wang, Thomas P. Condon, Transplantation	1998	63

Page 1